Advertisements

Йод Витрум

Quick links to important sections

Йод Витрум

Advertisements
Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Йод Витрум

What is Iodine Vitrum: Classification and Essence of the Preparation

Iodine Vitrum (Йод Витрум) is a pharmaceutical preparation that supplies the essential trace element iodine in the form of Potassium Iodide. This agent is classified as a Thyroid preparation and a Metabolic agent, reflecting its role in core human biological functions. It is a synthetic, single-ingredient product (monopreparation) designed to deliver iodide ions. Iodine is an essential trace element necessary for the synthesis of thyroid hormones.


Composition and Dosage Form: Active Ingredient Potassium Iodide

The preparation’s active core is the standardized compound Potassium Iodide (INN: Йодид калия). This inorganic salt is formulated as coated Tablets, a solid dosage form intended for oral administration. This format ensures a precise quantity of iodide ions is delivered to the body. The tablet format is used for its stability and ease of standardized intake, which is important for addressing variations in natural iodine levels.


General Purpose: The Role of Iodine in Supporting the Thyroid Gland

The general purpose of Iodine Vitrum is to serve as a source of iodine, which acts as the substrate for the natural synthesis of thyroid hormones by the thyroid gland. By providing this precursor material, the preparation supports normal thyroid function and is intended to prevent conditions associated with insufficient dietary iodine. This supportive action facilitates the gland’s ability to produce the hormones necessary for regulating metabolism, growth, and development.

Regulatory References

  1. NIH Office of Dietary Supplements (ODS) Fact Sheet on Iodine
Advertisements

What side effects are possible with Йод Витрум?

Possible Side Effects and Safety Information

The safety profile of Potassium Iodide, the active ingredient in Йод Витрум, is structured by government regulatory agencies into several key domains, focusing primarily on its interaction with the endocrine system and potential for hypersensitivity.

Adverse reactions are officially categorized by affected organ systems, including Endocrine System Disorders, Gastrointestinal Disorders, and Immune System Disorders. Common adverse reactions documented in regulatory sources include gastrointestinal upset (such as nausea and stomach discomfort) and various forms of skin rash.

Key Regulatory Safety Classifications

Category Officially Documented Characteristics
Serious Reactions Severe hypersensitivity, angioedema, and iodine-induced hyperthyroidism are documented as potential serious reactions.
Duration-Related Patterns The syndrome known as Iodism (metallic taste, increased salivation, or symptoms resembling a head cold) is explicitly associated with prolonged administration or high doses.
Endocrine Safety Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) are officially listed as possible adverse effects.

Safety restrictions caution against its use in patients with known hypersensitivity to iodides and those with conditions such as Dermatitis herpetiformis or hypocomplementemic vasculitis. Special considerations are noted for specific populations; for example, its use in pregnant and nursing women is associated with the risk of causing fetal or infant thyroid suppression, and caution is required for older adults or those with pre-existing thyroid conditions.

This official safety structure emphasizes that potential risks are mainly related to iodine overload and pre-existing physiological vulnerabilities, clearly defining the regulatory limits and documented reactions for the medicine.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Йод Витрум (Potassium Iodide) details specific manifestations and mandated emergency actions. Acute toxicity may present with severe events such as laryngeal edema, pulmonary oedema, and cardiopulmonary collapse. Chronic or high-dose exposure, known as Iodism, is documented through symptoms including metallic taste, severe headache, soreness of teeth and gums, and acneform skin lesions. Severe systemic effects, such as delirium and stupor, are also officially noted.

Immediate medical help must be sought for any suspected overdose or immediately for signs of severe distress, including trouble breathing or irregular heartbeat. The regulatory information emphasizes that no specific antidote is known; therefore, treatment is limited to supportive and symptomatic care. Procedural constraints apply: gastric lavage should not be performed due to the documented risk of exacerbating corrosive gastrointestinal injury.

A critical population-specific note is included for neonates (infants under 1 month), who are at the highest risk of developing hypothyroidism from iodide overload. Following overdose exposure, close follow-up of thyroid function is essential for all patients.

Advertisements

Therapeutic Uses of Йод Витрум

What Йод Витрум Treats: Main Uses and Benefits

The primary purpose of Йод Витрум is to offer symptomatic relief and supportive therapeutic benefit across acute contexts. The medication is considered relevant in clinical settings marked by heightened patient distress and is focused on easing the impact of temporary yet intense symptom patterns.

The medication is relevant when short-term symptomatic assistance is needed for managing acute symptom escalation, providing relief from distressing manifestations, and supporting conditions with episodic patterns. It addresses symptom clusters that may become intense or disruptive, especially when they create noticeable interference with daily stability. It may assist with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

“It is applied across domains where additional symptomatic support is needed.”


Quick Fact: Relief for Distressing Manifestations

Йод Витрум offers symptomatic relief that may help patients cope more steadily with symptom fluctuations and may contribute to improved comfort during periods of heightened symptoms. It is applied when appropriate during phases when symptoms become more noticeable, providing support that may help ease the overall symptom burden.

Advertisements

Eligibility and Restrictions for Use

Official Population Eligibility for Йод Витрум

This section outlines who can and cannot use the medicine, Potassium Iodide, according to official government regulatory documents.


Contraindicated Populations

Use of this medicine is absolutely prohibited for individuals with known severe sensitivity to iodides or the product's components. It is also contraindicated in patients with dermatitis herpetiformis (Duhring's disease) and hypocomplementemic vasculitis.

Populations with certain untreated or severe pre-existing conditions, such as toxic thyroid gland adenoma and severe adrenal insufficiency (Addison's disease), are also restricted from use.


Age and Physiological Restrictions

Population Group Eligibility Status (Regulatory)
Infants (< 1 month) Use is restricted; repeated doses are not recommended due to risk of transient hypothyroidism.
Adults (> 40 years) Not recommended for prophylaxis unless exposure is very high, due to increased risk of pre-existing thyroid disorders.
Pregnant Women Permitted for protection, but strictly not recommended for repeated doses to avoid risk of fetal thyroid suppression.
Breastfeeding Women Permitted; repeated doses are also strictly not recommended.

Conditional Use and Comorbidity

Patients with pre-existing thyroid disorders (e.g., Goitre) or impaired renal function require caution and close monitoring during use. These restrictions establish the boundaries for administration, ensuring the medicine is used only by approved populations under defined conditions.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Potassium Iodide (the active ingredient in Йод Витрум) specifies interactions across two primary domains, focusing strictly on documented interaction patterns and outcomes.

Interactions Affecting the Thyroid Axis

Co-administration of the preparation with specific medicines, including antithyroid drugs (Thionamides) and Lithium preparations, is officially restricted or requires caution. These pharmacodynamic interactions are documented to carry a risk of potentiating hypothyroid effects or exacerbating goiter. Regulatory restrictions govern the use of these combinations to address the potential for clinically significant interference with thyroid function.

Interactions Affecting Electrolyte Balance

A separate class of exposure-altering interactions relates to the potassium component of the medication, which may elevate the risk of hyperkalemia (high blood potassium) when combined with other agents that affect potassium balance. These interactions are documented with Potassium-sparing Diuretics (such as Spironolactone), Angiotensin-Converting Enzyme (ACE) Inhibitors, and Angiotensin II Receptor Blockers (ARBs). Specific examples listed in regulatory documents include Enalapril and Lisinopril.

Timing and Population-Specific Notes

Official labeling notes that ingesting the medicine with food or milk may impact the rate of iodide absorption. Additionally, patients with impaired renal function exhibit reduced iodide clearance, which is documented to increase the potential for accumulation and heighten the risk of interaction-related effects, particularly hyperkalemia.

Advertisements

Mechanism of Action

Thyroid Hormone Synthesis Pathway

Йод Витрум provides iodide (I^-), the essential and mandatory substrate that initiates the synthesis of thyroid hormones. The mechanism begins with the Sodium-Iodide Symporter (NIS) actively transporting iodide into the thyroid follicular cells. Once inside, the Thyroid Peroxidase (TPO) enzyme catalyzes the oxidation of iodide and its subsequent covalent binding to tyrosine residues on thyroglobulin, a process termed organification. This action completes the molecular cascade required for the formation of the signaling molecules thyroxine (T4) and triiodothyronine (T3).

Systemic Metabolic Modulation

Following release, the resulting hormones exert their mechanistic influence by binding to nuclear receptors in target cells across the body. This receptor-ligand interaction alters gene transcription, leading to the modified synthesis of various proteins. This mechanism effectively modulates fundamental cellular processes, including energy expenditure, thermogenesis, and oxygen consumption, which defines the physiological scope of the drug's action on core metabolic pathways.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Йод Витрум

The usage of Йод Витрум (Potassium Iodide) is defined by established guidelines, primarily covering its administration route, dosing, and frequency for two distinct applications: continuous nutritional support and urgent thyroid blocking during a radiation emergency.

Administration and Dosing Principles

Feature Official Instruction
Route of Administration Oral. The preparation is taken by mouth using the tablet form.
Preparation Details Tablets may be swallowed whole, or they can be crushed and mixed with liquid (such as water, juice, or formula) for patients who cannot swallow solid forms.
Low-Dose Frequency For continuous prophylactic use (prevention of deficiency), the medication is typically administered once daily.
Timing Relative to Meals For general daily use, the tablets are generally instructed to be taken after meals to aid tolerance and facilitate compliance with long-term use.

Dosing Across Use Contexts

The specific dose is dependent on the goal and the patient’s age. The standard daily dose for adults for deficiency prevention typically falls between 100 mu g and 200 mu g of iodine.

  • Population-Specific Prophylaxis: Doses are adjusted for physiological needs; for instance, the required dose for pregnant or breastfeeding women is commonly set at 200 mu g daily, while lower doses (50 mu g to 100 mu g) are used for younger pediatric patients.
  • Emergency Dosing Constraint: In a public health emergency, significantly higher doses (e.g., 130 mg for adults) are used, but administration must only proceed upon explicit directive from public health authorities and must not be taken more frequently than once every 24 hours.

This structured approach is intended to ensure the product is used in alignment with its specific defined purpose, whether as a long-term nutritional supplement or a constrained, short-term protective agent.

Advertisements

Recent Clinical Evidence

Evidence for Deficiency Prevention and Correction

The research base for this agent was studied in the context of iodine deficiency disorders (IDD). The evidence landscape includes Randomized Controlled Trials (RCTs) and Controlled Trials (CTs) that have evaluated different supplementation approaches. Large-scale public health programs and systematic reviews have also contributed to the overall evidence landscape. Researchers monitored populations in areas characterized by insufficient iodine intake to understand how these measures influence physiological balance.

Studies monitored several key outcomes related to functional imbalance, primarily focusing on the thyroid gland. Trials monitored biomarkers such as Urinary Iodine Concentration (UIC), which reflects recent intake. Studies monitored outcomes related to thyroid morphology, such as the size of the thyroid gland (Goiter prevalence), often using ultrasound. Studies monitored the measured values of these specific deficiency markers. The evidence contributes to the broader landscape of understanding how systemic iodine status may be monitored.

Outcomes Studied in Deficiency Research

This section summarizes the specific physiological measures that research has examined. Studies were conducted during periods of temporary physiological imbalance to monitor and track key indicators. Outcomes related to systemic or functional imbalance and physiological strain were monitored. Specifically, research describes the monitoring of the Thyroid Stimulating Hormone (TSH) and the tracking of various thyroid hormone levels (T4 and T3). These outcomes, monitored over defined time intervals, help show what has been observed so far in terms of the body's physiological patterns following iodine support.

Evidence in Special Populations

The evidence was evaluated in groups with increased physiological demand for iodine, notably pregnant and lactating women and school-age children. Research examined these populations in settings where iodine insufficiency may be a concern. Studies explored short-term changes in maternal thyroid parameters, such as the gland's volume and specific hormone levels, following supplementation.

For children, studies examined neurodevelopmental outcomes as measured by validated functional scores in children whose mothers received iodine during pregnancy or who received supplementation themselves during childhood. Findings for the most definitive cognitive benefits in children born to mothers with only mild deficiency were mixed across systematic reviews. The evidence suggests where more consistent and robust data may be needed in these specific subgroups.

Long-Term Research and Follow-up

Research has explored the periods for which measured iodine status remained stable or changed and the long-term patterns associated with supplementation. Follow-up durations were limited in many initial intervention trials, which primarily focused on short-term changes in biomarkers. Studies help show what has been observed so far over periods ranging from a few months up to one year.

Research Gaps and Areas of Uncertainty

The overall evidence quality varies across studies, and several areas of uncertainty remain. One primary research limitation is that results apply only to the specific populations studied, which often lived in areas with moderate to severe deficiency. Comparative evidence is lacking for certain specific intervention strategies. A significant point of uncertainty is the effect of iodine supplementation in populations that are only mildly-to-moderately deficient.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Йод Витрум (FAQ)


Q: Can I crush or split the tablets if they are difficult to swallow?

Yes, official administration instructions state that the tablets may be swallowed whole, chewed, or crushed and mixed with liquid, such as water or juice. This method is permitted to make the medicine easier to use, especially for children or individuals who cannot swallow solid forms.


Q: Is the medication considered a long-term treatment or a temporary measure?

Official regulatory documents define the medicine for two distinct uses. It can be used for continuous, long-term support to prevent iodine deficiency, or it may be used as a constrained, short-term protective agent in a public health radiation emergency. The intended duration of use is determined by the specific purpose, which should be discussed with a healthcare provider.


Q: Can older people or seniors use Йод Витрум?

Official guidance generally does not recommend the use of this medicine for prophylaxis (deficiency prevention) in adults over 40 years of age. This is due to regulatory caution regarding the potential for pre-existing thyroid conditions, which require careful management when using iodine products.


Q: Is there a risk of developing an allergic reaction to Йод Витрум?

Yes, official safety information documents that hypersensitivity and allergic reactions are among the possible adverse effects. These reactions can range from a skin rash to more severe forms, such as swelling of the face and throat (angioedema).


Q: Does taking the drug with food change its absorption?

Regulatory information indicates that ingesting the medicine alongside food or milk may impact the rate at which the iodide is absorbed by the body. For general daily use, official administration guidelines describe taking the tablets after meals to potentially aid tolerance.


Q: Is there a possibility of an interaction with herbal supplements?

The official regulatory profile lists specific documented interactions with certain prescription medications. It does not explicitly describe interactions with herbal supplements, but the use of all other supplements is typically considered part of a comprehensive review of potential interactions.


Q: Is it possible for the drug to cause stomach upset?

Yes, regulatory sources list gastrointestinal upset as a common adverse reaction. This may include symptoms such as nausea, vomiting, or general stomach discomfort, which can occur during use.


Q: Is Йод Витрум the same as other iodine supplements?

Йод Витрум is a pharmaceutical preparation that delivers iodine in the specific, regulated chemical form of Potassium Iodide (KI). As a pharmaceutical preparation (Thyroid preparation), its specific chemical form and intended use differ from those of general nutritional supplements.


Q: How long does it usually take to see any effect from taking Йод Витрум?

The primary goal is to ensure the body has sufficient iodide, the essential building block for thyroid hormones. Research studies monitored changes in key biomarkers (indicators of iodine status) over intervals ranging from a few months up to one year to track the physiological changes following supplementation.


Q: Is it necessary to have a doctor's test before starting Йод Витрум?

Official guidance emphasizes that individuals with pre-existing thyroid disorders or impaired kidney function require caution and close monitoring during use. These patient groups often have their needs and status reviewed before starting use, though regulatory documents do not mandate pre-use testing for all general users.


Q: What is the difference between potassium iodide and the iodine in this drug?

The drug is the inorganic salt Potassium Iodide (KI). This compound serves as the active ingredient that reliably delivers the essential trace element, iodine, to the body in the form of iodide ions (I^-). The potassium iodide is the chemical vehicle for the iodine.


Q: Do studies suggest that taking this drug can help prevent certain conditions?

Yes, the research base primarily focuses on the prevention and correction of Iodine Deficiency Disorders (IDD). By ensuring the availability of iodine, the medicine supports normal thyroid function to prevent the health conditions associated with insufficient dietary iodine.


Q: Does Йод Витрум interact with common pain relievers like ibuprofen?

Official drug interaction profiles caution that combining potassium-containing products, such as potassium iodide, with certain drug classes may pose a risk. Specifically, using it alongside Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen may increase the chance of elevated potassium levels in the blood (hyperkalemia).


Q: Is there a maximum time frame for how long Йод Витрум can be used?

Official information mentions that the syndrome known as Iodism (symptoms like a metallic taste or symptoms resembling a cold) is associated with prolonged administration or high doses. However, regulatory texts do not define a specific maximum duration for nutritional use.


Q: Is it normal to feel a change in energy levels when starting the drug?

The medicine works by supporting thyroid hormones, which modulate fundamental cellular processes like energy expenditure and metabolism. While official adverse reaction lists do not usually detail subjective energy changes, some people have reported related feelings such as unusual tiredness as a potential side effect.


Q: Is there any risk of taking too much iodine if I also eat iodine-rich foods?

The official safety profile emphasizes that potential risks are mainly related to iodine overload. High cumulative intake, including from both food and the medicine, can lead to adverse effects, such as iodine-induced hyperthyroidism or hypothyroidism.


Q: Why do official documents mention 'euthyroid state' in relation to this drug?

Official regulatory texts use the term euthyroid state to describe the medical goal of the medicine, which is to support the body in achieving and maintaining normal, healthy thyroid function. The nutritional support aims to sustain this proper physiological balance.


Q: Can men and women use Йод Витрум for the same purpose?

Yes, the core purpose of deficiency prevention applies equally to men and women. While special dosing is described for pregnant and breastfeeding women due to their increased physiological needs, the medicine's general use is consistent across genders.


Q: What information is available regarding the long-term use of this medicine?

Research has explored long-term use by monitoring iodine status over periods up to one year to track changes. Official safety information also notes that the syndrome of Iodism is specifically associated with prolonged administration.


Q: Are there different forms of the drug, like liquid or drops?

The product is officially formulated as coated Tablets intended for oral administration. While instructions permit the tablets to be crushed and mixed with liquid, no separate liquid or drop formulation is described in the core regulatory documents.


Q: What is the connection between iodine deficiency and pregnancy, concerning this drug?

Regulatory evidence was specifically evaluated in pregnant and lactating women because they have an increased physiological demand for iodine. Adequate iodine is critical during pregnancy as it is necessary for fetal thyroid hormone synthesis, which is essential for proper neurodevelopmental outcomes.


Q: Is it safe to take a cold or flu medicine while using Йод Витрум?

Ingredients commonly found in cold and flu medicines, such as NSAIDs (pain relievers) or decongestants, are noted in regulatory warnings as having potential interaction risk when used with potassium-containing products.


Q: Are there specific times of day that are better for taking Йод Витрум?

For general daily use, official administration guidelines describe the tablets as typically being taken after meals. This timing is generally advised to help the body tolerate the medicine and to facilitate compliance for long-term use.


Q: Do experts recommend this drug universally for all people?

No. Official guidance defines specific groups (contraindicated populations) who absolutely cannot use the drug. Additionally, the medicine is not generally recommended for prophylaxis for all age groups, such as infants under one month or adults over 40.


Q: Is the medicine approved for use in all age groups?

No. Regulatory documents state that use is restricted for infants younger than one month, and repeated doses are specifically not recommended in this group. Furthermore, prophylaxis is generally not recommended for adults over 40 years of age.


Q: Does the drug have any known effects on kidney or liver function?

Official information documents that the iodide clearance is reduced in patients with impaired renal (kidney) function. This can increase the potential for the medicine to accumulate in the body and heighten the risk of adverse effects, particularly the risk of high blood potassium (hyperkalemia).


Q: Are there any specific warnings for people with heart conditions?

While heart conditions are not a primary contraindication, regulatory guidance notes that high potassium levels (hyperkalemia) resulting from drug interactions can cause effects such as an irregular heartbeat. Furthermore, caution is required for people with pre-existing thyroid disorders, which can indirectly impact heart function.


Q: Can the effectiveness of the drug vary between different people?

Studies and regulatory-cited evidence were evaluated across different population groups, including pregnant women and children with varying physiological needs. Research limitations also acknowledge that results apply only to the specific populations studied, suggesting that individual responses may vary.


Q: Does research confirm the benefits of this drug for children?

Research has examined pediatric populations to track biomarkers and specific outcomes. While studies confirmed the importance of tracking iodine status, findings regarding the most definitive cognitive benefits in children were noted to be mixed across systematic reviews.


Q: Is it described in official sources how the drug affects mood or sleep?

Official regulatory documents do not list 'mood' or 'sleep' as primary adverse reaction categories. However, related Central Nervous System (CNS) effects, such as confusion and headache, are officially documented as potential adverse events.

Advertisements

How should Йод Витрум be stored and disposed of?

How to Store and Dispose of Йод Витрум

Storage of Йод Витрум (Potassium Iodide) must comply strictly with labeled regulatory requirements to maintain product stability. Tablets must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F). The product must be protected from excessive moisture and light and must be kept in its original container, tightly closed. A mandatory storage constraint is to keep the medicine out of the sight and reach of children.

For disposal, regulatory instructions prohibit discarding unused or expired tablets via household trash or wastewater (e.g., sink or toilet). The product must be disposed of according to local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Йод Витрум found in:

A-Z Index: